Author(s):
Mohammed H. Taleb, Eman K. Syam, Ihab M. Almasri, Mariam Hassan, Mahmoud M. Tawfick
Email(s):
almataleb21@gmail.com , emakha233@gmail.com , ihabalmasri@yahoo.com , mariam.hassan@pharma.cu.edu.eg , mahmoud_tawfick@azhar.edu.eg
DOI:
10.52711/0974-360X.2024.00640
Address:
Mohammed H. Taleb1, Eman K. Syam1, Ihab M. Almasri2, Mariam Hassan3,4, Mahmoud M. Tawfick5,6*
1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University-Gaza, Gaza 79702, Palestine.
2Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Gaza 79702, Palestine.
3Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.
4Department of Microbiology and Immunology, Faculty of Pharmacy, Galala University, New Galala City, Suez, Egypt.
5Department of Microbiology and Immunology, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt
6Department of Microbiology and Immunology, Faculty of Pharmacy (For Boys), Al-Azhar University, Cairo 11751, Egypt.
*Corresponding Author
Published In:
Volume - 17,
Issue - 9,
Year - 2024
Cite this article:
Mohammed H. Taleb, Eman K. Syam, Ihab M. Almasri, Mariam Hassan, Mahmoud M. Tawfick. Evaluation of Immune-Inflammatory and Other Biomarkers in Severe COVID-19 Patients with Diabetes Mellitus: A Cross-Sectional Study. Research Journal of Pharmacy and Technology. 2024; 17(9):4131-1. doi: 10.52711/0974-360X.2024.00640